Mo, Y., Zhang, Q., Wang, M., Chen, J., Hu, W., Chen, C., . . . Shen, S. Results from patient-derived xenograft models support co-administration of allopurinol and 6-mercaptopurine to reduce hepatotoxicity and improve event-free survival in pediatric acute lymphoblastic leukemia. Ferrata Storti Foundation.
Chicago Style (17th ed.) CitationMo, Yixiao, et al. Results from Patient-derived Xenograft Models Support Co-administration of Allopurinol and 6-mercaptopurine to Reduce Hepatotoxicity and Improve Event-free Survival in Pediatric Acute Lymphoblastic Leukemia. Ferrata Storti Foundation.
MLA (9th ed.) CitationMo, Yixiao, et al. Results from Patient-derived Xenograft Models Support Co-administration of Allopurinol and 6-mercaptopurine to Reduce Hepatotoxicity and Improve Event-free Survival in Pediatric Acute Lymphoblastic Leukemia. Ferrata Storti Foundation.